Kruppel-like Factor 4 (KLF4) Activates the Transcription of the Gene for the Platelet Isoform of Phosphofructokinase (PFKP) in Breast Cancer

被引:99
作者
Moon, Jong-Seok [1 ]
Kim, Hee Eun [1 ]
Koh, Eunjin [1 ]
Park, Se Ho [2 ]
Jin, Won-Ji [1 ]
Park, Byeong-Woo [2 ]
Park, Sahng Wook [1 ]
Kim, Kyung-Sup [1 ]
机构
[1] Yonsei Univ, Ctr Chron Metab Dis Res, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol,Coll Med,Inst Genet Sci, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Dept Surg, Brain Korea Project Med Sci 21, Seoul 120752, South Korea
关键词
ASCITES TUMOR-CELLS; DNA-DAMAGE; EXPRESSION; OVEREXPRESSION; TRANSFORMATION; PROGRESSION; ONCOGENE; PROMOTER; CLONING; GROWTH;
D O I
10.1074/jbc.M111.236737
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Kruppel-like factor 4 (KLF4) is a transcription factor that plays an important role in cell differentiation, proliferation, and survival, especially in the context of cancers. This study revealed that KLF4 activates glycolytic metabolism in breast cancer cells by up-regulating the platelet isoform of phosphofructokinase (PFKP). KLF4 activated the transcription of the PFKP gene by directly binding to the PFKP promoter. Whereas glucose uptake and lactate production were inhibited by the knockdown of KLF4, they were activated by the overexpression of KLF4. Unlike PFKP, the expressions of the other isoforms of phosphofructokinase and glycolytic genes were unaffected by KLF4. The human breast cancer tissues showed a close correlation between KLF4 and PFKP expression. This study also showed that PFKP plays a critical role in cell proliferation in breast cancer cells. In conclusion, it is suggested that KLF4 plays a role in maintenance of high glycolytic metabolism by transcriptional activation of the PFKP gene in breast cancer cells.
引用
收藏
页码:23808 / 23816
页数:9
相关论文
共 28 条
[1]
Atsumi T, 2002, CANCER RES, V62, P5881
[2]
Induction of KLF4 in basal keratinocytes blocks the proliferation - differentiation switch and initiates squamous epithelial dysplasia [J].
Foster, KW ;
Liu, ZL ;
Nail, CD ;
Li, XN ;
Fitzgerald, TJ ;
Bailey, SK ;
Frost, AR ;
Louro, ID ;
Townes, TM ;
Paterson, AJ ;
Kudlow, JE ;
Lobo-Ruppert, SM ;
Ruppert, JM .
ONCOGENE, 2005, 24 (09) :1491-1500
[3]
Foster KW, 1999, CELL GROWTH DIFFER, V10, P423
[4]
Foster KW, 2000, CANCER RES, V60, P6488
[5]
A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells [J].
GarrettSinha, LA ;
Eberspaecher, H ;
Seldin, MF ;
deCrombrugghe, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (49) :31384-31390
[6]
Why do cancers have high aerobic glycolysis? [J].
Gatenby, RA ;
Gillies, RJ .
NATURE REVIEWS CANCER, 2004, 4 (11) :891-899
[7]
KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia [J].
Huang, CC ;
Liu, ZL ;
Li, XN ;
Bailey, SK ;
Nail, CD ;
Foster, KW ;
Frost, AR ;
Ruppert, JM ;
Lobo-Ruppert, SM .
CANCER BIOLOGY & THERAPY, 2005, 4 (12) :1401-1408
[8]
Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30
[9]
Medina RA, 2002, BIOL RES, V35, P9, DOI 10.4067/S0716-97602002000100004
[10]
Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors [J].
Minchenko, OH ;
Ochiai, A ;
Opentanova, IL ;
Ogura, T ;
Minchenko, DO ;
Caro, J ;
Komisarenko, SV ;
Esumi, H .
BIOCHIMIE, 2005, 87 (11) :1005-1010